Financials
- Market Capitalization 3.17 B
- Employee 1 371
- Founded 2010
- CEO Emil Kakkis
- Website www.ultragenyx.com
- Headquarter Delaware, United States
- FIGI BBG001RWPDW6
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-3.95
売上高対価格比率
3.37
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 1626 | ARQT Arcutis Biotherapeutics, Inc. - Common stock | 27.01 USD | -0.41% | -1.24% | +9.71% | +69.45% | 3.38 B USD | ||
| 1632 | DYN Dyne Therapeutics, Inc. - Common Stock | 23.95 USD | +1.31% | -0.21% | +29.74% | +2.31% | 3.42 B USD | ||
| 1662 | BEAM Beam Therapeutics Inc. - Common Stock | 31.35 USD | +1.13% | -15.11% | +5.03% | +46.91% | 3.23 B USD | ||
| 1671 | IDYA IDEAYA Biosciences, Inc. - Common Stock | 36.67 USD | +1.44% | -8.78% | +24.60% | +12.55% | 3.22 B USD |